It's pleasing to see some well-known pharmaceutical names are moving up the table in the latest Sitemorse benchmark of the websites of major companies in the life science sector.
This survey remains the most consistent in scores and recorded rises and falls tend to be smaller than in other surveys we carry out. The top performers this time have scores that are unchanged, a tribute to their consistency. It's good to see some well-known names towards the top, so well done Sanofi Aventis, Eli Lilley and Sandoz.
Highest of the big names is Eli Lilley's Swiss site, which has risen 9 places to take 14th position. Behind them is the recently-introduced Sandoz Pharmaceuticals AG website which has moved from 18th to 17th position with an unchanged score of 6.51, the same mark as the previous two surveys.
Cutting-edge pharmaceutical company Geneva-based Novimmune - leading the war on the treatment of inflammatory diseases and immune-related disorders - keeps top position, with an overall score of 8.1 of a possible ten marks in the benchmark.
Taking second place in the survey is Siegfried AG with 7.8, a riser of ten places. Siegfried, headquartered in Zofingen, Switzerland, has been a consistent performer in Sitemorse tests. The company operates worldwide and has around 800 employees manufacturing active pharmaceutical ingredients.
Third is Newron Pharmaceuticals S.p.A, whose mission is discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) such as Parkinson's. Maintaining an overall score of 7.6 this time, Newron have been consistently at the top of our global life science benchmark tables for the last couple of years.